Lisa Schnirring | News Editor | CIDRAP NewsJun 26, 2020At a cost of an estimated $31 billion, new vaccines, treatments, and diagnostics are urgently needed.
Huge global effort to fast-track COVID-19 tools advances
More from COVID-19More posts in COVID-19 »
- Global, US data show high antibiotic use, rise in resistant infections during COVID
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
- Study reveals promising results for abatacept for severe COVID
- Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy